Bottom line
JAMCX vs JPPEX: the short answer
JAMCX (JPMorgan Mid Cap Value Fund) and JPPEX (JPMorgan Mid Cap Equity Fund) are both mutual funds.
JPPEX is cheaper at 0.6% vs 1.04% — a difference of $44 a year per $10,000 invested.
Over five years, JAMCX returned +8.2% a year vs +7.5% for JPPEX.
JAMCX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
JAMCX vs JPPEX side by side
| JAMCX | JPPEX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | J.P. Morgan | J.P. Morgan |
| Category | Mid-Cap | Mid-Cap |
| Expense ratio | 1.04% | 0.6% |
| Annual cost per $10k | $104 | $60 |
| 10-yr cost on $10k (prospectus) | $1,880 | $861 |
| Max front load | 5.25% | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | −0.9% | +6.3% |
| 5-yr return (annualized) | +8.2% | +7.5% |
| 10-yr return (annualized) | +7.8% | +10.9% |
| Best quarter | +19.2% | +25.2% |
| Worst quarter | −31.9% | −23.7% |
| Net assets (fund) | $11.2B | $6.2B |
| Number of holdings | 105 | 208 |
| Portfolio turnover | 68% | 97% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JAMCX | JPPEX | Difference |
|---|---|---|---|
| 2025 | +4.6% | +6.3% | −1.7% |
| 2024 | +13.8% | +14.3% | −0.5% |
| 2023 | +10.9% | +16.5% | −5.6% |
| 2022 | −8.5% | −15.8% | +7.4% |
| 2021 | +29.5% | +20.3% | +9.2% |
| 2020 | −0.1% | +23.0% | −23.0% |
| 2019 | +26.0% | +33.2% | −7.2% |
| 2018 | −12.1% | −8.0% | −4.1% |
| 2017 | +13.1% | +21.5% | −8.4% |
| 2016 | +14.1% | +7.5% | +6.5% |
Source: Fund prospectus bar charts
Holdings overlap
21 of JAMCX's top 25 holdings also appear in JPPEX's top 25.
| Holding | JAMCX | JPPEX |
|---|---|---|
| JPMorgan Prime Money Market Fund | 4.26% | 2.89% |
| IQVIA Holdings, Inc. | 2.31% | 1.75% |
| MKS, Inc. | 2.16% | 1.73% |
| Silgan Holdings, Inc. | 1.76% | 1.21% |
| Healthpeak Properties, Inc. | 1.73% | 1.20% |
| AMETEK, Inc. | 1.71% | 1.43% |
| Ameriprise Financial, Inc. | 1.61% | 1.11% |
| M&T Bank Corp. | 1.60% | 1.10% |
| First Citizens BancShares, Inc. | 1.52% | 1.05% |
| Omnicom Group, Inc. | 1.50% | 1.03% |
| Quest Diagnostics, Inc. | 1.49% | 1.03% |
| Dover Corp. | 1.49% | 1.03% |
| CDW Corp. | 1.44% | 0.99% |
| Loews Corp. | 1.41% | 0.98% |
| Middleby Corp. (The) | 1.37% | 0.94% |
Source: SEC Form N-PORT
JAMCX top 10
- JPMorgan Prime Money Market Fund — 4.26%
- IQVIA Holdings, Inc. — 2.31%
- MKS, Inc. — 2.16%
- Silgan Holdings, Inc. — 1.76%
- Healthpeak Properties, Inc. — 1.73%
- AMETEK, Inc. — 1.71%
- Ameriprise Financial, Inc. — 1.61%
- M&T Bank Corp. — 1.60%
- First Citizens BancShares, Inc. — 1.52%
- Omnicom Group, Inc. — 1.50%
JPPEX top 10
- JPMorgan Prime Money Market Fund — 2.89%
- IQVIA Holdings, Inc. — 1.75%
- MKS, Inc. — 1.73%
- AMETEK, Inc. — 1.43%
- Cencora, Inc. — 1.39%
- Jabil, Inc. — 1.37%
- Silgan Holdings, Inc. — 1.21%
- Healthpeak Properties, Inc. — 1.20%
- Fidelity National Information Services, Inc. — 1.12%
- Ameriprise Financial, Inc. — 1.11%
FAQ
What is the difference between JAMCX and JPPEX?
Which is cheaper, JAMCX or JPPEX?
Should I own both JAMCX and JPPEX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.